hl7

{"resourceType":"MedicationRequest","id":"medrx0317","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative: MedicationRequest\u003c/b\u003e\u003ca name\u003d\"medrx0317\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource MedicationRequest \u0026quot;medrx0317\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003eidentifier\u003c/b\u003e: id: 12345689 (use: OFFICIAL)\u003c/p\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: completed\u003c/p\u003e\u003cp\u003e\u003cb\u003eintent\u003c/b\u003e: order\u003c/p\u003e\u003ch3\u003eMedications\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eReference\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003e\u003ca name\u003d\"med0303\"\u003e \u003c/a\u003e\u003cblockquote\u003e\u003cp/\u003e\u003cp\u003e\u003ca name\u003d\"med0303\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: Alemtuzumab 10mg/ml (Lemtrada) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"http://terminology.hl7.org/5.1.0/CodeSystem-v3-rxNorm.html\"\u003eRxNorm\u003c/a\u003e#1594660)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003cp\u003e\u003cb\u003esubject\u003c/b\u003e: \u003ca href\u003d\"patient-example-a.html\"\u003ePatient/pat1: Donald Duck\u003c/a\u003e \u0026quot;Donald DUCK\u0026quot;\u003c/p\u003e\u003cp\u003e\u003cb\u003eauthoredOn\u003c/b\u003e: 2015-01-15\u003c/p\u003e\u003cp\u003e\u003cb\u003erequester\u003c/b\u003e: \u003ca href\u003d\"practitioner-example-f007-sh.html\"\u003ePractitioner/f007: Patrick Pump\u003c/a\u003e \u0026quot;Simone HEPS\u0026quot;\u003c/p\u003e\u003ch3\u003eReasons\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eConcept\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eChronic Lymphoid Leukemia (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#92814006)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edosageInstruction\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esequence\u003c/b\u003e: 1\u003c/p\u003e\u003cp\u003e\u003cb\u003etext\u003c/b\u003e: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/p\u003e\u003cp\u003e\u003cb\u003eadditionalInstruction\u003c/b\u003e: Rapidly increase dose until tolerated \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e, Administer on alternate days \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etiming\u003c/b\u003e: Duration 12weeks, 3 per 1 weeks\u003c/p\u003e\u003cp\u003e\u003cb\u003eroute\u003c/b\u003e: Intravenous route (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#47625008)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003emethod\u003c/b\u003e: Inject - dosing instruction imperative (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#422145002)\u003c/span\u003e\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edoseAndRate\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edosageInstruction\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esequence\u003c/b\u003e: 2\u003c/p\u003e\u003cp\u003e\u003cb\u003etext\u003c/b\u003e: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/p\u003e\u003cp\u003e\u003cb\u003eadditionalInstruction\u003c/b\u003e: Rapidly increase dose until tolerated \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e, Administer on alternate days \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etiming\u003c/b\u003e: Duration 12weeks, 3 per 1 weeks\u003c/p\u003e\u003cp\u003e\u003cb\u003eroute\u003c/b\u003e: Intravenous route (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#47625008)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003emethod\u003c/b\u003e: Inject - dosing instruction imperative (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#422145002)\u003c/span\u003e\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edoseAndRate\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edosageInstruction\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esequence\u003c/b\u003e: 3\u003c/p\u003e\u003cp\u003e\u003cb\u003etext\u003c/b\u003e: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/p\u003e\u003cp\u003e\u003cb\u003eadditionalInstruction\u003c/b\u003e: Rapidly increase dose until tolerated \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e, Administer on alternate days \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etiming\u003c/b\u003e: Duration 12weeks, 3 per 1 weeks\u003c/p\u003e\u003cp\u003e\u003cb\u003eroute\u003c/b\u003e: Intravenous route (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#47625008)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003emethod\u003c/b\u003e: Inject - dosing instruction imperative (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#422145002)\u003c/span\u003e\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edoseAndRate\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/div\u003e"},"contained":[{"resourceType":"Medication","id":"med0303","code":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1594660","display":"Alemtuzumab 10mg/ml (Lemtrada)"}]}}],"identifier":[{"use":"official","system":"http://www.bmc.nl/portal/prescriptions","value":"12345689"}],"status":"completed","intent":"order","medication":{"reference":{"reference":"#med0303"}},"subject":{"reference":"Patient/pat1","display":"Donald Duck"},"authoredOn":"2015-01-15","requester":{"reference":"Practitioner/f007","display":"Patrick Pump"},"reason":[{"concept":{"coding":[{"system":"http://snomed.info/sct","code":"92814006","display":"Chronic Lymphoid Leukemia (disorder)"}]}}],"dosageInstruction":[{"sequence":1,"text":"Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk","additionalInstruction":[{"text":"Rapidly increase dose until tolerated"},{"text":"Administer on alternate days"}],"timing":{"repeat":{"duration":12,"durationUnit":"wk","frequency":3,"period":1,"periodUnit":"wk"}},"route":{"coding":[{"system":"http://snomed.info/sct","code":"47625008","display":"Intravenous route (qualifier value)"}]},"method":{"coding":[{"system":"http://snomed.info/sct","code":"422145002","display":"Inject - dosing instruction imperative (qualifier value)"}]},"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":3,"unit":"mg","system":"http://unitsofmeasure.org","code":"mg"}}]},{"sequence":2,"text":"Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk","additionalInstruction":[{"text":"Rapidly increase dose until tolerated"},{"text":"Administer on alternate days"}],"timing":{"repeat":{"duration":12,"durationUnit":"wk","frequency":3,"period":1,"periodUnit":"wk"}},"route":{"coding":[{"system":"http://snomed.info/sct","code":"47625008","display":"Intravenous route (qualifier value)"}]},"method":{"coding":[{"system":"http://snomed.info/sct","code":"422145002","display":"Inject - dosing instruction imperative (qualifier value)"}]},"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":10,"unit":"mg","system":"http://unitsofmeasure.org","code":"mg"}}]},{"sequence":3,"text":"Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk","additionalInstruction":[{"text":"Rapidly increase dose until tolerated"},{"text":"Administer on alternate days"}],"timing":{"repeat":{"duration":12,"durationUnit":"wk","frequency":3,"period":1,"periodUnit":"wk"}},"route":{"coding":[{"system":"http://snomed.info/sct","code":"47625008","display":"Intravenous route (qualifier value)"}]},"method":{"coding":[{"system":"http://snomed.info/sct","code":"422145002","display":"Inject - dosing instruction imperative (qualifier value)"}]},"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":30,"unit":"mg","system":"http://unitsofmeasure.org","code":"mg"}}]}],"meta":{"tag":[{"system":"http://terminology.hl7.org/CodeSystem/v3-ActReason","code":"HTEST","display":"test health data"}]}}